The versatility of biological products to treat disease never before considered has led numerous biopharmaceutical companies recently to announce expansions of production bioreactor capacity in the ...
Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells. Exozymes can replace ...
Continuous manufacturing (CM) has become a contentious topic in the modern pharmaceutical lexicon, driven by divergent ...
Enduro Genetics, a Denmark-based start-up, aims to increase efficiency in biomanufacturing. By getting producing cells ...
Devices and Getinge have recently announced their partnership under which they will integrate Getinge’s bioreactors with 908 ...
The collaboration aims to enhance muscle-fiber growth, elongation and fusion into mature muscle tissue, while also boosting ...
Such growth makes China an increasingly important player in the global biopharmaceutical industry, offering potential market ...
Key Laboratory of Low-Grade Energy Utilization Technologies and Systems, Chongqing University, Ministry of Education, Chongqing 400044, China ...
On Jan. 15, 2025, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the facility’s bioreactor, the vessel used to grow organisms and cells. According to the ...
20% of bioreactor runs at the Genzyme facility failed due to contamination or quality issues over 2.5 years. FDA identified 84 overdue deviation investigations, some exceeding 180 days ...
However, traditional high-field NMR systems and bioreactor platforms pose challenges, including the need for specialized equipment and fixed sample volumes. This study introduces a scalable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback